These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 6852442

  • 1. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.
    Igimi H, Asakawa S, Watanabe D, Shimura H.
    Gastroenterol Jpn; 1983 Apr; 18(2):93-7. PubMed ID: 6852442
    [Abstract] [Full Text] [Related]

  • 2. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS, Salen G, Shefer S.
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [Abstract] [Full Text] [Related]

  • 3. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
    Podda M, Zuin M, Dioguardi ML, Festorazzi S, Dioguardi N.
    Hepatology; 1982 Oct; 2(3):334-9. PubMed ID: 7076116
    [Abstract] [Full Text] [Related]

  • 4. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
    Salvioli G, Salati R.
    Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
    [Abstract] [Full Text] [Related]

  • 5. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
    Sahlin S, Ahlberg J, Angelin B, Ewerth S, Nilsell K, Reihnér E, Einarsson K.
    Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
    [Abstract] [Full Text] [Related]

  • 6. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
    Carulli N, Ponz De Leon M, Zironi F, Pinetti A, Smerieri A, Iori R, Loria P.
    J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
    [Abstract] [Full Text] [Related]

  • 7. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
    Hirota I, Chijiiwa K, Noshiro H, Nakayama F.
    Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL, Larusso NF, Hofmann AF, Turcotte J, Carlson GL, Ott BJ.
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [Abstract] [Full Text] [Related]

  • 10. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog.
    Cohen BI, Singhal AK, Stenger RJ, May-Donath P, Finver-Sadowsky J, McSherry CK, Mosbach EH.
    Hepatology; 1984 Feb; 4(2):300-7. PubMed ID: 6706304
    [Abstract] [Full Text] [Related]

  • 11. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
    Xiao ZL, Biancani P, Carey MC, Behar J.
    Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
    [Abstract] [Full Text] [Related]

  • 12. [Nucleation time and growth time in patients with cholesterol gallstone--factors affecting nucleation time and growth time and effect of UDCA and CDCA].
    Nomura Y.
    Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1103-13. PubMed ID: 2795947
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of biliary bile acid concentration and composition on the calcium level in human gallbladder bile.
    Tamasawa N, Yoneda M, Makino I, Takebe K, Sone K, Kogawa R.
    Tohoku J Exp Med; 1993 Dec; 171(4):297-307. PubMed ID: 8184404
    [Abstract] [Full Text] [Related]

  • 15. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [Abstract] [Full Text] [Related]

  • 16. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K.
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [Abstract] [Full Text] [Related]

  • 17. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D, Brenner G, Pratschke E, Paumgartner G.
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [Abstract] [Full Text] [Related]

  • 18. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
    Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L.
    Hepatology; 1982 Jan; 2(6):804-10. PubMed ID: 7141392
    [Abstract] [Full Text] [Related]

  • 19. Effects of fatty acid esters of cheno- and ursodeoxycholic acids on gallstone formation in hamsters.
    Kritchevsky D, Klurfeld DM, Sirtori C.
    Pharmacol Res Commun; 1986 Nov; 18(11):997-1002. PubMed ID: 3797448
    [Abstract] [Full Text] [Related]

  • 20. [Comparative study of the effects of an average dose of chenodesoxycholic acid and a high dose of ursodesoxycholic acid (dosage equivalents: 15 mg/kg/day) on the composition of lipids and bile acids in the bile of patients with radiotransparent biliary lithiasis].
    Garrido G, Bretó M, Pérez F, Berenguer J.
    Rev Clin Esp; 1986 Nov; 170(1-2):31-6. PubMed ID: 6635274
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.